Crossmark

Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment

Crossref DOI link: https://doi.org/10.1016/j.rceng.2020.07.004

Published Print: 2020-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Boixeda, R.

Campins, L.

Juanola, J.

Force, L.
License Information

Text and Data Mining valid from 2020-11-01
More Information

This article is maintained by: Elsevier

Article Title: Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment

Journal Title: Revista Clínica Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2020.07.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2020.07.001

Content Type: simple-article

Copyright: © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.